Marc Andrew Sala

Dr. Marc Andrew Sala

orcid

Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
4 October 2024 in Nature Immunology
Verified
Journal Article
Open access
PDF file
JBJoseph I Bailey
Joseph I Bailey
CPConnor H Puritz
Connor H Puritz
KSKarolina J Senkow
Karolina J Senkow
NMNikolay S Markov
Nikolay S Markov
EDEstefani Diaz
Estefani Diaz
MSMarc Andrew Sala
Marc Andrew Sala
Monocyte-derived alveolar macrophages drive lung injury and fibrosis in murine models and are associated with pulmonary fibrosis in humans. Monocyte-derived alveolar macrophages have been suggested to develop a phenotype that promotes lung repair as injury resolves. We compared single-cell and cytokine profiling of the alveolar space in a cohort of 35 patients with post-acute sequelae of COVID-19 who had persistent respiratory symptoms and abnormalities on a computed tomography scan of the chest that subsequently improved or progressed. The abundance of monocyte-derived alveolar macrophages, their gene expression programs, and the level of the monocyte chemokine CCL2 in bronchoalveolar lavage fluid positively associated with the severity of radiographic fibrosis. Monocyte-derived alveolar macrophages from patients with resolving or progressive fibrosis expressed the same set of profibrotic genes. Our findings argue against a distinct reparative phenotype in monocyte-derived alveolar macrophages, highlighting their utility as a biomarker of failed lung repair and a potential target for therapy.

22 May 2019 in BMC Medical Genomics
Verified
Journal Article
Open access
PDF file
JIJustin Ideozu
Justin Ideozu
VRVittobai Rangaraj
Vittobai Rangaraj
Hiam Abdala-ValenciaHiam Abdala-Valencia
Hiam Abdala-Valencia
XZXi Zhang
Xi Zhang
MKManoj Kandpal
Manoj Kandpal
HLHara Levy
Hara Levy
In cystic fibrosis (CF), impaired immune cell responses, driven by the dysfunctional CF transmembrane conductance regulator (CFTR) gene, may determine the disease severity but clinical heterogeneity remains a major therapeutic challenge. The characterization of molecular mechanisms underlying impaired immune responses in CF may reveal novel targets with therapeutic potential. Therefore, we utilized simultaneous RNA sequencing targeted at identifying differentially expressed genes, transcripts, and miRNAs that characterize impaired immune responses triggered by CF and its phenotypes. Peripheral blood mononuclear cells (PBMCs) extracted from a healthy donor were stimulated with plasma from CF patients (n = 9) and healthy controls (n = 3). The PBMCs were cultured (1 × 105 cells/well) for 9 h at 37 ° C in 5% CO2. After culture, total RNA was extracted from each sample and used for simultaneous total RNA and miRNA sequencing. Analysis of expression signatures from peripheral blood mononuclear cells induced by plasma of CF patients and healthy controls identified 151 genes, 154 individual transcripts, and 41 miRNAs differentially expressed in CF compared to HC while the expression signatures of 285 genes, 241 individual transcripts, and seven miRNAs differed due to CF phenotypes. Top immune pathways influenced by CF included agranulocyte adhesion, diapedesis signaling, and IL17 signaling, while those influenced by CF phenotypes included natural killer cell signaling and PI3K signaling in B lymphocytes. Upstream regulator analysis indicated dysregulation of CCL5, NF-κB and IL1A due to CF while dysregulation of TREM1 and TP53 regulators were associated with CF phenotype. Five miRNAs showed inverse expression patterns with three target genes relevant in CF-associated impaired immune pathways while two miRNAs showed inverse expression patterns with two target genes relevant to a dysregulated immune pathway associated with CF phenotypes. Our results indicate that miRNAs and individual transcript variants are relevant molecular targets contributing to impaired immune cell responses in CF.

27 October 2021 in Pediatric Pulmonology
Verified
Journal Article
Closed access
PDF file
MSMarc Andrew Sala
Marc Andrew Sala
KVKaitlyn M. Vitale
Kaitlyn M. Vitale
MPMichelle Prickett
Michelle Prickett

15 January 2020 in American Journal of Respiratory and Critical Care Medicine
Verified
Journal Article
Open access
MSMarc Andrew Sala
Marc Andrew Sala
MJManu Jain
Manu Jain

3 February 2022 in Nutrition in Clinical Practice
Verified
Journal Article
Closed access
PDF file
JSJessica M. Shape
Jessica M. Shape
MSMarc Andrew Sala
Marc Andrew Sala

27 April 2021 in Radiology
Verified
Journal Article
Closed access
ADAlejandro A. Diaz
Alejandro A. Diaz
LCLaura A. Colangelo
Laura A. Colangelo
YOYuka Okajima
Yuka Okajima
AYAndrew Yen
Andrew Yen
MSMarc Andrew Sala
Marc Andrew Sala
RKRavi Kalhan
Ravi Kalhan
In healthy adults aged 18–30 years, the preservation of cardiorespiratory fitness over 20 years was associated with lower odds of bronchiectasis at CT at year 25 of a 30-year follow-up. Background Protective factors against the risk of bronchiectasis are unknown. A high level of cardiorespiratory fitness is associated with a lower risk of chronic obstructive pulmonary disease. But...